Assessment of insulin secretion in relation to insulin resistance

Purpose of reviewIn healthy individuals, upregulation of insulin secretion compensates for insulin resistance so that normal glucose tolerance is maintained. Thus insulin secretion should be evaluated in relation to insulin sensitivity, as failure to account for insulin resistance may prevent the detection of β-cell defects. Numerous studies have considered this problem, but how insulin secretion is regulated by insulin sensitivity and how insulin secretion should be quantitatively expressed to account for sensitivity are issues still under debate. This review will discuss these concepts and the aspects that should be considered for an appropriate solution to the problem. Recent findingsWhile the historical paradigm of a specific hyperbolic relationship between some particular insulin secretion and insulin sensitivity indices has recently been confirmed, it has been suggested that this paradigm is not applicable to all the indices. It has also been suggested that for some relevant insulin secretion indices this relationship may not exist. Thus, the classical insulin secretion index that accounts for sensitivity, the so-called disposition index, should be used cautiously, as it presupposes a hyperbolic relationship. Furthermore, it has been pointed out that the assessment of this relationship requires independency of the indices. SummaryThe assessment of insulin secretion in relation to insulin sensitivity is important in the study of glycemic control but requires appropriate methods and cautious interpretations. Blind application of principles that are valid for specific insulin secretion and sensitivity indices may produce false results.

[1]  K. Zierler,et al.  Forearm metabolism in obesity and its response to intra-arterial insulin. Characterization of insulin resistance and evidence for adaptive hyperinsulinism. , 1962, The Journal of clinical investigation.

[2]  R. Bergman,et al.  Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. , 1981, The Journal of clinical investigation.

[3]  R. Bergman,et al.  Quantification of the Relationship Between Insulin Sensitivity and β-Cell Function in Human Subjects: Evidence for a Hyperbolic Function , 1993, Diabetes.

[4]  M. Byrne,et al.  Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. , 1995, The Journal of clinical investigation.

[5]  R N Bergman,et al.  Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors. , 1996, The Journal of clinical investigation.

[6]  A Mari,et al.  How to measure insulin sensitivity , 1998, Journal of hypertension.

[7]  M. Matsuda,et al.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. , 1999, Diabetes care.

[8]  C. Bogardus,et al.  The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. , 1999, The Journal of clinical investigation.

[9]  A. de Leiva,et al.  Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test , 2000, Diabetologia.

[10]  M. Stumvoll,et al.  Comment on: M. Albarada et al. (2000) Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test. Diabetologia 43: 1507–1511 , 2001, Diabetologia.

[11]  R. Bergman,et al.  Accurate assessment of beta-cell function: the hyperbolic correction. , 2002, Diabetes.

[12]  R. Bergman,et al.  Accurate Assessment of β-Cell Function: The Hyperbolic Correction , 2002 .

[13]  B. Ahrén,et al.  Quantification of insulin secretion in relation to insulin sensitivity in nondiabetic postmenopausal women. , 2002, Diabetes.

[14]  Andrea Mari,et al.  Methods for clinical assessment of insulin sensitivity and β-cell function , 2003 .

[15]  M. Matsuda,et al.  Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study , 2003, Diabetologia.

[16]  Andrea Mari,et al.  Methods for clinical assessment of insulin sensitivity and beta-cell function. , 2003, Best practice & research. Clinical endocrinology & metabolism.

[17]  M. Stumvoll,et al.  Altered homeostatic adaptation of first- and second-phase beta-cell secretion in the offspring of patients with type 2 diabetes: studies with a minimal model to assess beta-cell function. , 2003, Diabetes.

[18]  S. Kahn,et al.  The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes , 2003, Diabetologia.

[19]  S. Kahn,et al.  Impact of Intra-Abdominal Fat and Age on Insulin Sensitivity and β-Cell Function , 2004 .

[20]  J. Chiasson,et al.  Prevention of type 2 diabetes: insulin resistance and beta-cell function. , 2004, Diabetes.

[21]  A. Mari,et al.  Beta cell function and its relation to insulin action in humans: a critical appraisal , 2004, Diabetologia.

[22]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[23]  M. Stumvoll Control of glycaemia: from molecules to men. Minkowski Lecture 2003 , 2004, Diabetologia.

[24]  G. Pacini,et al.  Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies. , 2004, European journal of endocrinology.

[25]  The hyperbolic law—a 25-year perspective , 2005, Diabetologia.

[26]  re: Gastaldelli A, Ferrannini E, Miyazaki Y, Matsuda M, DeFronzo RA (2004) Beta cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia 47:31–39 , 2004, Diabetologia.

[27]  S. Kahn,et al.  Impact of intra-abdominal fat and age on insulin sensitivity and beta-cell function. , 2004, Diabetes.

[28]  Re: The hyperbolic law--a 25-year perspective. , 2005, Diabetologia.

[29]  Masafumi Matsuda,et al.  beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. , 2005, The Journal of clinical endocrinology and metabolism.

[30]  E. Ferrannini,et al.  Characterization of beta-cell function impairment in first-degree relatives of type 2 diabetic subjects: modeling analysis of 24-h triple-meal tests. , 2005, American journal of physiology. Endocrinology and metabolism.

[31]  S. Merhar,et al.  Letter to the editor , 2005, IEEE Communications Magazine.

[32]  G. Pacini,et al.  Islet adaptation to insulin resistance: mechanisms and implications for intervention , 2005, Diabetes, obesity & metabolism.

[33]  A. Brazzale,et al.  Comparative evaluation of simple insulin sensitivity methods based on the oral glucose tolerance test , 2005, Diabetologia.